[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
PubMed Central Update.
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: PubMed Central Update.
- From: "Hamaker, Chuck" <cahamake@email.uncc.edu>
- Date: Tue, 14 Sep 1999 15:15:12 EDT
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
According to the new issue of British Medical Journal So far, seven organisations have signalled their participation in PubMed Central, of which only three publish original scientific material. The publishers of Molecular Biology of the Cell (www.molbiolcell.org) have offered its content, with a two month delay, on an experimental basis. They "strongly support the ultimate goal of barrier-free access." http://www.bmj.com/cgi/content/full/319/7211/657/a for full news release (aug. 31st) from Varmus, et. al. see: http://www.nih.gov/welcome/director/pubmedcentral/pubmedcentral.htm PubMed Central: An NIH-Operated Site for Electronic Distribution of Life Sciences Research Reports In the four months since we proposed E-biomed - a system that would make results from the world's life sciences research community freely available on the Internet - we have heard from hundreds of people and have had discussions with dozens of interested organizations. Whether they support or oppose the proposal, these commentators have made valuable suggestions, many of which have been incorporated into this statement. ..We now invite the scientific community to engage in this exciting new venture. We plan to be ready to make reports accessible through PubMed Central by January 2000. Publishers, societies, editorial boards and other organizations interested in depositing content in PubMed Central are urged to contact us at PubMedCentral@nih.gov.
- Prev by Date: Re: Congratulations to AAAS (and a few others)
- Next by Date: Re: Article based subscription
- Prev by thread: Re: SPARC and ACS (other views)
- Next by thread: pricing questions: perspective from a publisher
- Index(es):